Biotechnology Stocks II Performance Guide: Relay Therapeutics, Inc. (RLAY)
RLAY has no dividends.
Table and Chart of RLAY Performance
See what a $1,000 investment in RLAY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RLAY Returns | |
|---|---|
| Start Date | Aug-31-2020 |
| Start Price | $40.19 |
| End Date | May-17-2024 |
| End Price | $6.64 |
| # Prices | 46 |
| Min Date | Apr-30-2024 |
| Min Price | $6.52 |
| Max Date | Nov-30-2020 |
| Max Price | $53.31 |
| Total Return | -83.48% |
| Annualized Return | -37.48% |
| Current Value of $1,000 Purchase | $165 |
| Number Returns | 1,035 |
| Average Return | -42.12% |
| Number Profitable Returns | 77 |
| Percent Profitable Returns | 7.44% |
| Number Unprofitable Returns | 958 |
| Percent Unprofitable Returns | 92.56% |
| Profitable to Unprofitable Returns Ratio | 0.08 |
| RLAY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $881,407,000 |
| Beta | 1.681 | Price to Sales | 36.10 |
| Earnings per Share | $-2.6300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 1.227 |
| PRICE DATA | |
| 52 Week High | $13.32 |
| 52 Week Low | $5.7 |
| Analyst Target Price | $21.96 |
| 50-Day Moving Average | $7.19 |
| 200-Day Moving Average | $8.85 |
| FINANCIAL DATA | |
| Revenue per Share | $0.283 |
| Revenue | $35,327,000 |
| Profit Margin | 0% |
| Return on Equity | -40.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RLAY Compare Returns with S&P 500
RLAY Trendline Chart
RLAY Moving Average Chart
RLAY Stock Return Map - See Patterns of Gains and Losses
RLAY Stock Returns/Purchase Dates